TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Onkologia AB
Closing information (x1000 EUR)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
108
|
130
|
122 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
88
|
112
|
109 |
| EBITDA |
87
|
111
|
103 |
| Total assets |
468
|
414
|
329 |
| Current assets |
109
|
140
|
126 |
| Current liabilities |
5
|
12
|
14 |
| Equity capital |
463
|
402
|
315 |
| - share capital |
5
|
4
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
98.9%
|
97.1%
|
95.7% |
| Turnover per employee |
108
|
130
|
122 |
| Profit as a percentage of turnover |
81.5%
|
86.2%
|
89.3% |
| Return on assets (ROA) |
18.8%
|
27.1%
|
33.1% |
| Current ratio |
2180.0%
|
1166.7%
|
900% |
| Return on equity (ROE) |
19.0%
|
27.9%
|
34.6% |
| Change turnover |
-25
|
3
|
19 |
| Change turnover % |
-19%
|
2%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.